東和薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/11/05 | 3,085 | 3,085 | 3,000 | 3,015 | -70 | -2.3% | 82,400 |
| 2024/11/01 | 3,105 | 3,145 | 3,070 | 3,085 | -65 | -2.1% | 71,900 |
| 2024/10/31 | 3,110 | 3,150 | 3,100 | 3,150 | +55 | +1.8% | 78,300 |
| 2024/10/30 | 3,100 | 3,110 | 3,070 | 3,095 | +5 | +0.2% | 428,700 |
| 2024/10/29 | 3,090 | 3,095 | 3,040 | 3,090 | +15 | +0.5% | 59,900 |
| 2024/10/28 | 3,055 | 3,095 | 3,015 | 3,075 | +20 | +0.7% | 50,700 |
| 2024/10/25 | 3,085 | 3,095 | 3,030 | 3,055 | ±0 | ±0% | 63,100 |
| 2024/10/24 | 3,020 | 3,070 | 3,015 | 3,055 | -10 | -0.3% | 72,700 |
| 2024/10/23 | 3,080 | 3,090 | 3,055 | 3,065 | -20 | -0.6% | 51,100 |
| 2024/10/22 | 3,095 | 3,095 | 3,040 | 3,085 | ±0 | ±0% | 69,400 |
| 2024/10/21 | 3,115 | 3,115 | 3,070 | 3,085 | -45 | -1.4% | 56,700 |
| 2024/10/18 | 3,120 | 3,145 | 3,095 | 3,130 | +40 | +1.3% | 58,800 |
| 2024/10/17 | 3,085 | 3,100 | 3,070 | 3,090 | +5 | +0.2% | 48,700 |
| 2024/10/16 | 3,050 | 3,110 | 3,025 | 3,085 | +20 | +0.7% | 69,100 |
| 2024/10/15 | 3,100 | 3,130 | 3,065 | 3,065 | -35 | -1.1% | 73,700 |
| 2024/10/11 | 3,100 | 3,110 | 3,080 | 3,100 | -5 | -0.2% | 59,600 |
| 2024/10/10 | 3,090 | 3,110 | 3,065 | 3,105 | ±0 | ±0% | 40,000 |
| 2024/10/09 | 3,100 | 3,125 | 3,075 | 3,105 | -5 | -0.2% | 66,000 |
| 2024/10/08 | 3,135 | 3,170 | 3,110 | 3,110 | -65 | -2% | 63,700 |
| 2024/10/07 | 3,180 | 3,190 | 3,105 | 3,175 | +15 | +0.5% | 71,000 |
| 2024/10/04 | 3,095 | 3,185 | 3,050 | 3,160 | +80 | +2.6% | 102,800 |
| 2024/10/03 | 3,075 | 3,095 | 3,050 | 3,080 | +50 | +1.7% | 78,300 |
| 2024/10/02 | 3,030 | 3,095 | 3,025 | 3,030 | -40 | -1.3% | 58,000 |
| 2024/10/01 | 3,035 | 3,085 | 3,010 | 3,070 | +60 | +2% | 61,600 |
| 2024/09/30 | 3,000 | 3,040 | 2,980 | 3,010 | -55 | -1.8% | 67,000 |
| 2024/09/27 | 3,080 | 3,120 | 3,025 | 3,065 | -60 | -1.9% | 85,600 |
| 2024/09/26 | 3,090 | 3,145 | 3,055 | 3,125 | +40 | +1.3% | 140,300 |
| 2024/09/25 | 3,065 | 3,085 | 3,010 | 3,085 | +35 | +1.1% | 70,300 |
| 2024/09/24 | 3,030 | 3,075 | 3,030 | 3,050 | +52 | +1.7% | 108,200 |
| 2024/09/20 | 2,991 | 3,020 | 2,973 | 2,998 | +7 | +0.2% | 79,900 |
| 2024/09/19 | 2,975 | 3,020 | 2,975 | 2,991 | +33 | +1.1% | 68,600 |
| 2024/09/18 | 2,950 | 2,975 | 2,929 | 2,958 | +31 | +1.1% | 56,200 |
| 2024/09/17 | 2,966 | 3,000 | 2,902 | 2,927 | -1 | ±0% | 67,400 |
| 2024/09/13 | 2,970 | 2,970 | 2,923 | 2,928 | -53 | -1.8% | 81,800 |
| 2024/09/12 | 2,922 | 2,994 | 2,920 | 2,981 | +90 | +3.1% | 81,400 |
| 2024/09/11 | 2,889 | 2,913 | 2,866 | 2,891 | -29 | -1% | 120,600 |
| 2024/09/10 | 2,929 | 2,949 | 2,909 | 2,920 | -1 | ±0% | 83,300 |
| 2024/09/09 | 2,881 | 2,925 | 2,834 | 2,921 | -29 | -1% | 115,600 |
| 2024/09/06 | 2,978 | 3,000 | 2,935 | 2,950 | -13 | -0.4% | 64,800 |
| 2024/09/05 | 2,975 | 2,995 | 2,940 | 2,963 | +38 | +1.3% | 57,000 |
| 2024/09/04 | 2,901 | 2,976 | 2,901 | 2,925 | -60 | -2% | 63,400 |
| 2024/09/03 | 2,920 | 2,989 | 2,920 | 2,985 | +81 | +2.8% | 78,800 |
| 2024/09/02 | 2,940 | 2,940 | 2,876 | 2,904 | -21 | -0.7% | 50,800 |
| 2024/08/30 | 2,916 | 2,939 | 2,916 | 2,925 | +7 | +0.2% | 47,500 |
| 2024/08/29 | 2,890 | 2,928 | 2,887 | 2,918 | +27 | +0.9% | 49,300 |
| 2024/08/28 | 2,856 | 2,903 | 2,854 | 2,891 | +18 | +0.6% | 36,200 |
| 2024/08/27 | 2,843 | 2,884 | 2,843 | 2,873 | +23 | +0.8% | 56,600 |
| 2024/08/26 | 2,831 | 2,863 | 2,816 | 2,850 | +1 | ±0% | 60,600 |
| 2024/08/23 | 2,839 | 2,854 | 2,812 | 2,849 | +49 | +1.8% | 89,500 |
| 2024/08/22 | 2,799 | 2,815 | 2,779 | 2,800 | -11 | -0.4% | 38,000 |
101～
150
件表示中 / 6926件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 東和薬品 | 253,000円 | +15.0% | -7.3% | 2.77% | 8.30倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 科研薬 | 444,100円 | +22.8% | +113.0% | 4.28% | 12.34倍 | 1.10倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 435,500円 | +7.1% | -35.0% | 2.76% | 36.01倍 | 1.01倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 222,900円 | +14.2% | +41.0% | 2.06% | 10.92倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
